epipen 0,3 mg/dosis injektionsv?ske, opl?sning
nordic prime aps - adrenalin - injektionsvæske, opløsning - 0,3 mg/dosis
sugammadex mylan
mylan ireland limited - sugammadex sodium - neuromuskulær blokade - alle andre terapeutiske produkter - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
sugammadex fresenius kabi
fresenius kabi deutschland gmbh - sugammadex sodium - neuromuskulær blokade - alle andre terapeutiske produkter - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
sugammadex "reddy" 100 mg/ml injektionsvæske, opløsning
reddy holding gmbh - sugammadexnatrium - injektionsvæske, opløsning - 100 mg/ml
mirabella 0,10+0,02 mg filmovertrukne tabletter
2care4 aps - ethinylestradiol, levonorgestrel - filmovertrukne tabletter - 0,10+0,02 mg
trilafon dekanoat 108,2 mg/ml injektionsvæske, opløsning, i.m.
orifarm a/s - perphenazindecanoat - injektionsvæske, opløsning, i.m. - 108,2 mg/ml
sugammadex amomed
aop orphan pharmaceuticals gmbh - sugammadex sodium - neuromuskulær blokade - alle andre terapeutiske produkter - tilbagevendelse af neuromuskulær blokade induceret af rocuronium eller vecuronium. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
sugammadex "qilu" 100 mg/ml injektionsvæske, opløsning
qilu pharma spain s.l. - sugammadexnatrium - injektionsvæske, opløsning - 100 mg/ml
epipen jr. 0,15 mg/dosis injektionsvæske, opløsning
orifarm a/s - adrenalin - injektionsvæske, opløsning - 0,15 mg/dosis
mirabella 0,10+0,02 mg filmovertrukne tabletter
epione medicine aps - ethinylestradiol, levonorgestrel - filmovertrukne tabletter - 0,10+0,02 mg